Camlin Fine Sciences Ltd

Camlin Fine Sciences Ltd

Next 500 2024
+ 6 More
+ 6 More
OVERVIEW
FINANCIALS

About

Camlin Fine Sciences (CFS) provides solutions like antioxidants, performance chemicals, and aroma ingredients for the extension of shelf life. Its diphenol derivatives are used in industries like food, fragrances, biofuel, aquaculture, pharmaceuticals, petrochemicals, agrochemicals, and dyes, among others. The company's specialities include food-grade antioxidants, antimicrobials, toxin binders, emulsifier blends, growth promoters, traditional and natural antioxidants, and more. In addition to manufacturing in India, its manufacturing facilities are located in China, Italy, Brazil, Mexico, and the USA. Its R&D facilities can also be found in Europe, the Americas, and Asia. The company is currently headquartered in Mumbai and led by Ashish Subhash Dandekar.

Incorporation Year: 1993
Headquarters: Mumbai
Top Management: Ashish Dandekar
Industry: Chemicals

Featured In Fortune India Ranking

Next 500 India
#312(2024)#262(2023)#211(2022)#231(2021)#346(2020)#395(2019)#500(2016)
#312(2024)#262(2023)#211(2022)#231(2021)#346(2020)#395(2019)#500(2016)
Ranking Trend Fortune Next 500 India

Financial Data 2024

Revenue
1,576
(INR Cr)
Net Operating Income
1,613
(INR Cr)
Assets
1,546
(INR Cr)
Profit
-93
(INR Cr)
Net Worth
820
(INR Cr)

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS2024202320222021202020192018201720162015201420132012201120102009
Revenue
(INR Cr)
1576
-12.0%
1790
22.8%
1459
24.2%
1175
9.6%
1072
15.7%
927
26.1%
735
26.2%
582
7.7%
541
-3.2%
559
10.0%
508
24.5%
408
8.1%
378
102.8%
186
32.0%
141
18.4%
119
-
Net Operating Income
(INR Cr)
1613
-4.07%
1682
19.08%
1412
18.95%
1187
13.15%
1049
17.60%
892
23.81%
721
34.96%
534
9.11%
489
-12.35%
558
9.75%
509
36.15%
374
11.45%
335
95.29%
172
22.38%
140
34.74%
104
28.10%
Profit
(INR Cr)
-93
-
52
-14.1%
61
19.1%
51
68.1%
30
-
1
-
-30
-
-11
-
36
-34.9%
55
91.7%
29
90.1%
15
298.4%
4
-46.7%
7
487.6%
1
-50.6%
2
-
Assets
(INR Cr)
1546
-5.2%
1630
13.5%
1436
13.4%
1266
26.4%
1001
12.1%
894
10.6%
808
43.5%
563
57.1%
358
21.0%
296
21.4%
244
27.8%
191
7.5%
178
55.5%
114
50.8%
76
31.3%
58
-
Net Worth
(INR Cr)
820
8.5%
756
13.6%
665
22.5%
543
34.7%
403
8.7%
371
-0.1%
371
74.6%
213
20.6%
176
30.7%
135
44.6%
93
42.7%
65
23.6%
53
13.9%
46
59.9%
29
-0.2%
29
4.6%
Employee Cost
(INR Cr)
179
9.9%
163
12.1%
145
20.5%
120
20.7%
100
13.5%
88
20.6%
73
19.3%
61
52.5%
40
-1.3%
41
18.1%
34
13.7%
30
27.6%
24
127.6%
10
34.0%
8
25.5%
6
-
Interest Cost
(INR Cr)
70664142484132312424252017976
Cash & Bank Balance
(INR Cr)
949914213865103483119191626101342
Total Debt
(INR Cr)
683801646550539461373331180160150126125684728

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS2024202320222021202020192018201720162015201420132012201120102009
Profit As % Of Revenues -2.9%4.2%4.3%2.8%0.1%--6.6%9.9%5.7%3.7%1.0%3.8%0.9%2.1%
Profit As % Of Assets -3.2%4.2%4.0%3.0%0.1%--10.0%18.6%11.8%7.9%2.1%6.2%1.6%4.2%
Profit As % Of Networth -6.9%9.1%9.4%7.5%0.2%--20.3%40.8%30.8%23.1%7.2%15.3%4.2%8.4%
Interest Cost to EBITDA % 207.2%32.6%25.9%22.7%35.2%56.2%198.8%96.1%28.0%28.3%40.0%42.8%56.9%59.0%54.0%43.7%
Debt to Equity Ratio 0.831.060.971.011.341.241.001.561.021.191.611.922.361.461.600.97
RONW -6.3%10.0%13.8%7.7%0.8%--23.0%48.2%36.2%25.6%6.4%6.2%3.7%7.5%
ROCE 1.4%10.8%11.1%14.5%11.9%7.3%0.2%5.4%22.8%28.4%27.4%23.7%17.5%12.3%15.2%18.0%